We read with interest the study by Go and colleagues 1 in which the authors report that among 59 772 adults with chronic heart failure, hemoglobin concentrations ([Hb]) Ͻ13 g/dL and glomerular filtration rates (GFR) Ͻ45 mL/min per 1.73 m 2 significantly predicted an increased risk of dying during the next 7 years (independently of each other, of age, and of left ventricular systolic function) compared with [Hb] of 13.0 to 13.9 g/dL and GFR Ն60 mL/min per 1.73 m 2 . The adjusted hazard ratio for death ranged from 1.2 (with [Hb] of 12 to 12.9 g/dL) to 3.5 (with [Hb] Ͻ9 g/dL) and from 1.4 (with GFR of 30 to 44 mL/min per 1.73 m 2 ) to 3.3 (with GFR Ͻ15 mL/min per 1.73 m 2 ). The authors invoke bone marrow depression, impaired erythropoietin production or function, tissue hypoxia, nutritional deficiencies, drug-induced side effects, fluid and neurohormonal imbalances, and accelerated ventricular remodeling as possible reasons for their findings. 1 We suggest an additional interpretation for the observations by Go and colleagues. Depressed progenitor cell availability, through blunted cardiovascular repair mechanisms, may contribute to explain the higher risk of death associated with low [Hb] and impaired kidney function. 2 Ischemic heart disease is the most common cause of heart failure, 1 and low [Hb], kidney dysfunction, and reduced circulating CD34ϩ progenitor cells are emerging as powerful predictors of death among ischemic heart disease patients. 3, 4 Interestingly, endothelial nitric oxide synthase is essential for progenitor cell mobilization. 2 We have investigated the relation among [Hb], GFR, and the number of circulating CD34ϩ in 52 hemodynamically stable ischemic heart disease patients. As expected, admission values of [Hb] were associated with GFR (Pϭ0.002, rϭ0.39). 4 However, only [Hb] (Pϭ0.009, ␤ϭ0.42)-and not GFR (Pϭ0.65)-significantly predicted the number of circulating CD34ϩ. Additionally, [Hb] predicted CD34ϩ in patients with GFR Ͼ45 mL/min per 1.73 m 2 (nϭ46, Pϭ0.02, ␤ϭ0.37) and also in those with GFR Ͻ45 mL/min per 1.73 m 2 (nϭ6, Pϭ0.006, betaϭ1.01). Among 83 similar ischemic heart disease patients, we investigated the relation between [Hb] and endogenous plasma nitric oxide metabolites. On multivariable analysis, reduced nitric oxide bioavailability (Pϭ0.01), but not C-reactive protein (Pϭ0.33), white cell count (Pϭ0.35), serum creatinine (Pϭ0.25), or other potential confounders, independently predicted admission [Hb] Ͻ13 g/dL. 5 We propose that low [Hb] may signal bone marrow depression, reduced CD34ϩ bioavailability, and impaired nitric oxide function, both in the presence and absence of kidney disease, representing a potentially powerful and integrated marker of cardiovascular risk.
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Disclosures
None.
Felicita Andreotti, MD, PhD, FESC Giulio Coluzzi, MD Filippo Crea, MD, FESC

Institute of Cardiology Catholic University Medical School
Rome, Italy
